Dr. Reddy’s Laboratories – Good Health Can’t Wait
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr Reddy - We believe in the power of unity, where diverse skills, a ...
Dr. Reddy’s has grown steadily from its origins in bulk drug manufacturing into an integrated global pharmaceutical enterprise. Our business is anchored in our purpose of accelerating access to affordable medicines for patients around the world.
Dr. Reddy’s Laboratories – Good Health Can’t Wait
2022年4月19日 · Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx announce potential partnership for joint development of affordable anti-malarial drug
Hyderabad, India, January 30, 2024: Dr. Reddys Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and nine months ended December 31, 2023.
Sustainable API Manufacturing & Development Process - Dr.
The Dr. Reddy’s API business is a leading manufacturer and supplier of high quality affordable Active Pharmaceutical Ingredients (API) to leading generic formulations manufacturers across the world, enabling them to accelerate access to affordable medicines for patients worldwide.
About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access …
Dr. Reddy's - Leading Pharmaceutical API Manufacturing Company
Dr. Reddy’s launches the first biosimilar darbepoetin alfa in the world and brings relief to millions of anaemia patients and in India under the brand name 'Cresp®', the only one in India. In the Active Ingredients business, the company filed 36 Drug Master Files (DMFs) in 2009-10.
Dr. Reddys at 5th CII LIFE SCIENCES SUMMIT 2023 | News | Dr.
Mr. Gunjan Singh, VP & Head (Europe & U.S.), API Sales and Marketing at Dr. Reddys API, shared profound insights at the recent summit themed "Making India a Global Pharma and Lifesciences Innovation Hub."
Top Brands - Dr. Reddy's Laboratories
For any Dr. Reddy’s product availability related issues, please contact us: Phone: 1800 425 0014 (Monday to Friday, 8AM to 6PM IST) Email:customerservices%40drreddys.com
Dr. Reddy's Laboratories announces agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolio Hyderabad, India; Basel, Switzerland; and Princeton, NJ, USA.